Clinical Trials Logo

Filter by:
NCT ID: NCT01992276 Withdrawn - Influenza Clinical Trials

Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection

Start date: December 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the rate of decline in quantitative viral load measured in hospitalized patients with Influenza A infection

NCT ID: NCT01991366 Withdrawn - Clinical trials for Acute Myocardial Infarction

Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary PCI for ST-Elevation MI?

Start date: October 2013
Phase:
Study type: Observational

The aim of this observational study is to evaluate the in hospital and 6 month outcomes of the use of Glycoprotein IIb/IIIa inhibitor eptifibatide as adjunctive therapy in patients undergoing primary Percutaneous Coronary Intervention for ST-elevation myocardial infarction in a large tertiary referral center. It is hypothesized that Glycoprotein IIb/IIIa inhibitor use during primary Percutaneous Coronary Intervention for ST-elevation myocardial infarction/ acute myocardial infarction is superior to unfractionated heparin alone or bivalirudin alone. Additionally, after propensity matching this superiority remains.

NCT ID: NCT01989897 Withdrawn - Allergic Rhinitis Clinical Trials

Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests

Start date: March 2013
Phase: Phase 1/Phase 2
Study type: Interventional

This is a double-blind study with respect to the diluents used, with patients known to be allergic to the specific allergen tested. Three study sites will be involved, each testing one allergen (Cat, Mite, Timothy grass pollen). Subjects who are known to be allergic to the allergen in question will be tested with serial three-fold dilutions to determine the ID 50 and relative extract potency using the method described by Turkeltaub.

NCT ID: NCT01988805 Withdrawn - Healthy Individuals Clinical Trials

Gene Polymorphism Study of Normal Individual Inflammasome Genes

Start date: February 2013
Phase: N/A
Study type: Observational

This study is intended to collect blood from healthy individuals to investigate whether variations in immune-related (inflammasome) genes affect how the immune cells found in the blood can help fight infections and prevent diseases.

NCT ID: NCT01988649 Withdrawn - Pain Clinical Trials

Oxytocin and Pain Sensitivity and Threshold

Start date: April 2015
Phase: N/A
Study type: Interventional

Oxytocin is neurohypophysial peptide that acts mainly as a neuromodulator in the brain. In addition,oxytocin have an important roles in sexual reproduction , in particular during and after childbirth. It facilitates birth, maternal bonding, and, breastfeeding. Nasal oxytocin has been commonly used to improve breastfeeding in lactating women. A review of safety , side effects and subjective reaction to intranasal oxytocin in human research in 1529 subjects did not review any differences from placebo. The vast majority of basic science studies suggested a large effect of oxytocin in minimizing acute pain.4 Few studies have demonstrated an association between plasma levels of oxytocin and pain in humans. No studies have examined the effect of intranasal oxytocin on pain sensitivity and threshold. Since addictive properties of oxytocin have not been described, the drug may have important application in the management of acute and chronic pain. The main objective of the current investigation was to evaluate the effect of intranasal oxytocin on pain sensitivity and threshold in human volunteers. We hypothesized that intranasal oxytocin, in human volunteers ,would decrease sensitivity and and increase pain threshold compared to intranasal saline . Significance: Intranasal oxytocin may become a viable treatment for acute and chronic pain in humans.

NCT ID: NCT01988038 Withdrawn - Clinical trials for Autosomal Dominant Polycystic Kidney Disease

Repository Study of Autosomal Dominant Polycystic Kidney Disease

Repository
Start date: November 2013
Phase: N/A
Study type: Observational [Patient Registry]

The design and establishment of the Polycystic Kidney Disease (PKD) Data Repository does not require, and may be constrained by, a narrowly conceived hypothesis. However, the PKD Repository has been designed to include demographic, clinical, biochemical, and genetic data that will further explore the natural history of the disorder and assess the factors that are likely to be associated with the progression of disease and the incidence of complications including renal failure, cardiovascular disease, and stroke.

NCT ID: NCT01986777 Withdrawn - Clinical trials for Cognitive Impairments

LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy

LDX
Start date: July 2013
Phase: N/A
Study type: Interventional

This is a double-blind, placebo-controlled, study testing whether LDX improves cognitive function and EF in 20 postmenopausal women who report onset of cognitive difficulties after oophorectomy (with or without subsequent chemo/adjunctive therapy). Brain imaging is included at critical time points to obtain objective data regarding effects of LDX as well as potential predictors of resilience in the face of oophorectomy.

NCT ID: NCT01986764 Withdrawn - Planned RRSO Clinical Trials

E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy

E2LDX
Start date: July 1, 2013
Phase: N/A
Study type: Interventional

This project seeks to address cognitive disturbance, which is a frequent adverse sequelae of riskreducing bilateral salpingo-oophorectomy (RRSO) with or without post-procedure chemotherapy and adjunctive treatments. RRSO after completion of childbearing is recommended for prevention of ovarian and breast cancer in women with BRCA1/BRCA2 mutations and standard of care for women with some forms of hormone-responsive cancer. Knowledge regarding the impact of this procedure, with or without chemotherapy, and subsequent hypogonadism on brain health is less than adequate. Premenopausal women who undergo an acute surgical menopause are at greater risk for verbal memory decline and executive function (EF) complaints, but as of yet, we cannot predict who is going to experience these adverse sequelae, nor do we have targeted prevention or treatment strategies other than hormone therapy, which is not an option in many cases and not always effective. An idealized sample as women who are planning for a RRSO will undergo brain imaging and behavioral assessments pre- and post-surgery as well as pre-/post-treatment with E2 or the psychostimulant, lisdexamphetamine (LDX; Vyvanse®).

NCT ID: NCT01986049 Withdrawn - Clinical trials for Obstetrical Complications From Sedation During Parturition

Transversus Abdominis Plane (TAP) Block for Post Caesarian Pain

TAPBlock
Start date: February 2013
Phase: Phase 3
Study type: Interventional

Adding TAP block with Bupivacaine may decrease the use of PCA bolus use after caesarean section for pain relief.

NCT ID: NCT01985100 Withdrawn - Clinical trials for Ischemic Cerebrovascular Accident

The Use of Hyperbaric Oxygen to Increase the Blood Supply in the Injured, But Still Alive Tissue, Around an Old Stroke

HBO
Start date: November 21, 2013
Phase: N/A
Study type: Interventional

To confirm or refute recently published data regarding the reduction in post-stroke ischemic penumbra, that used SPECT/CT, by using the more precise tools of PET/MRI.